Bio


Dr. Juarez-Reyes received her PhD in Health Psychology, MD and Internal Medicine residency training from the University of California at San Francisco. Her focus during medical training was in Behavioral Medicine. In 2010, she became board certified in Integrative Medicine through American Board of Integrative Holistic Medicine. She is currently a Clinical
Associate Professor in the Division of Primary Care and Population Health, Department of Medicine, Stanford University. She is currently the Director of Behavioral Health Group Medical Visits and serves as Site Director for Internal Medicine Residency program at Stanford. She developed “Beyond Stress”, a six-week group intervention for patients with stress, anxiety, and depression. This intervention has now been translated into Spanish, Mas Alla del Estres, and it is delivered to community based Spanish speaking cancer patients.
Her current research evaluates integrative behavioral health group medical visits and the relationship to anxiety, depression, burnout, and sleep in primary care and Spanish speaking community-based populations. Previous health disparities research includes tobacco cessation practices of community-based providers, breast cancer screening follow-up in Latinx women, Latinx adolescent reproductive behavior, medication eligibility criteria effects in ethnic subgroups, and TB treatment in urban county jails. She enjoys travel, walking with friends, anything science fiction and spending time with her family.

Clinical Focus


  • Internal Medicine
  • Women's Health
  • Behavioral Medicine

Academic Appointments


Administrative Appointments


  • Site Director, Internal Medicine Residency Program (2016 - Present)

Professional Education


  • Board Certification: American Board of Internal Medicine, Internal Medicine (2024)
  • Residency: UCSF-Graduate Medical Education (2001) CA
  • Medical Education: Univ of California San Francisco (1997) CA
  • M.D., U.C. San Francisco, Medicine (1997)
  • Ph.D., U.C. San Francisco, Psychology (1991)
  • B.A, San Jose State University, Psychology Neuroscience (1985)

Clinical Trials


  • Mental Health Disparities in Spanish Speaking Latina Breast Cancer Patients Not Recruiting

    The purpose of the study is to:Translate a mindfulness program into Spanish for Latina patients with breast cancer.Train a community health worker to facilitate the mindfulness program. Determine if this program is culturally acceptable and feasible, and Obtain pilot data on the program's effectiveness in reducing anxiety and depression

    Stanford is currently not accepting patients for this trial. For more information, please contact Olivia Tigre, MPH, 650-726-9907.

    View full details

2022-23 Courses


All Publications


  • A Randomized Controlled Trial of a Culturally Adapted, Community-Based, Remotely Delivered Mindfulness Program for Latinx Patients With Breast Cancer is Acceptable and Feasible While Reducing Anxiety. Global advances in integrative medicine and health Juarez-Reyes, M., Martinez, E., Xiao, L., Goldman Rosas, L. 2024; 13: 27536130241274240

    Abstract

    Few Spanish mindfulness interventions have been evaluated in Latinx patients with cancer. We culturally adapted a mindfulness intervention for Spanish speaking Latinx patients. The objective was to measure feasibility and acceptability as primary outcomes, with changes in anxiety, depression, and sleep as secondary outcomes.Spanish-speaking Latinx patients with breast cancer (n = 31) were randomized, between April 2021 and May 2022 to either intervention or wait-list control groups. The mindfulness intervention consisted of 6-weekly 1.5-hour sessions remotely delivered by a novice facilitator. Cultural adaptations included language, metaphor, goal, concept, trauma informed, and acknowledgement of spirituality. Feasibility was benchmarked as 75% of participants attending their first session, 75% of participants completing 4 of 6 sessions, and scoring ≥ 4 on a 5-point Likert feasability scale measuring ability to implement changes after 6-weeks. Acceptability was measured as scoring ≥ 4 on a 5-point Likert scale measuring usefulness and relevance of the mindfulness intervention for each session. An intention-to-treat, linear mixed model with repeated measures analysis examined changes in anxiety, depression, and sleep at week 6 and 18 (3 months post intervention).All three feasibility benchmarks were met with 75% of first session attendance, 96% of participants completing 4 of 6 sessions, and 94% scoring ≥ 4, on the feasibility scale (Mean (SD) = 4.3 (0.6)). Acceptability scores for both usefulness and relevance questions were ≥ 4 across all 6 sessions. Anxiety was significantly reduced at 3 months (-3.6 (CI -6.9, -0.2), P = .04), but is of unclear clinical significance given the small change. Depression scores declined, but not significantly, and there were no changes in sleep.This culturally adapted, remotely delivered mindfulness intervention using a novice facilitator was acceptable and feasible and demonstrated associated reductions in anxiety amongst Spanish speaking Latinx patients with breast cancer.ClinicalTrials.gov ID# NCT04834154.

    View details for DOI 10.1177/27536130241274240

    View details for PubMedID 39157776

    View details for PubMedCentralID PMC11329901

  • Behavioral health support for health care workers during COVID-19: An observational study of a remote mindfulness intervention JOURNAL OF WORKPLACE BEHAVIORAL HEALTH Juarez-Reyes, M., Less, J., Gardner, R. M., Dahlen, A., Blacker, A. 2024
  • Mindfulness-Based Group Medical Visits in Primary Care for Stress and Anxiety: An Observational Study. Journal of integrative and complementary medicine Juarez-Reyes, M., Purington, N., Kling, S. M. 2022

    Abstract

    Background: The prevalence of anxiety disorders in primary care is 20%, with 41% of these patients reporting no current treatment. Patients with anxiety are also more likely to have comorbidities with other medical and/or psychiatric conditions, increasing medical costs. Integrating mindfulness-based interventions (MBIs) into a group medical visit (GMV) format has been successfully used to manage pain, but limited literature is available on the effectiveness of these visit formats for patients with stress and anxiety. Methods: Ninety-two adult patients with self-reported stress and/or anxiety were recruited from three university outpatient primary care clinics between 2016 and 2019. Participants attended at least 4 of 6 weekly GMVs focused on MBIs. Change in heart rate, blood pressure, Generalized Anxiety Disorder-7 (GAD-7) score, and 9 item Patient Health Questionnaire (PHQ-9) score from the first to last visit were evaluated using mixed effect linear regression models. Results: Both GAD-7 (estimated change: -5.1; 95% confidence interval [CI]: -6.4 to -3.7) and PHQ-9 (estimated change: -3.3; 95% CI: -4.3 to -2.2) scores significantly decreased from the first to last visit. These reductions were independent of age, sex, and number of visits attended. No significant changes in heart rate or blood pressure were found. Conclusions: Significant reductions in anxiety and depression in primary care patients were observed after a 6-week standardized mindfulness based GMV. Intergroup variability was not significant indicating that the intervention is reproducible over time and across providers. Future randomized controlled trials with appropriate controls will better evaluate which components of the intervention account for findings.

    View details for DOI 10.1089/jicm.2021.0329

    View details for PubMedID 35671517

  • Accessing behavioral health care during COVID: rapid transition from in-person to teleconferencing medical group visits. Therapeutic advances in chronic disease Juarez-Reyes, M., Mui, H. Z., Kling, S. M., Brown-Johnson, C. 2021; 12: 2040622321990269

    Abstract

    Background and aim: Effective and safe behavioral health interventions in primary care are critical during pandemic and other disaster situations. California shelter-in-place orders necessitated rapid transition of an effective mindfulness-based medical group visit (MGV) program from in-person to videoconferenced sessions (VCSs). Aim: to Describe procedures, acceptability, and feasibility of converting from in-person to VCS.Patients and methods: Methods: qualitative. Dataset: primary care. Intervention: a six-session 2-h MGV program with educational and mindfulness components was converted. Four in-person sessions and two VCSs were held. General Anxiety Disorder and Patient Health Questionnaire-9 were administered at first and last sessions. A semi-structured focus group was conducted after session six. Population studied: six primary care patients (42±11years) with stress, anxiety, or depression participated.Results: Procedural changes included remote material distribution, scheduling, hosting, and facilitation functions using the Zoom platform. The focus group revealed that patients preferred in-person sessions during initial visits, but appreciated transitioning to VCS, which provided continued support during a challenging time. Instruction on technical (e.g. logging on) and social (e.g. signaling next speaker) aspects of VCS was suggested. Building relationships through conversations was an important part before and after in-person sessions missing from VCS. Patients suggested combining in-person and VCS to allow relationship building while also improving access.Conclusion: While many procedural changes were needed to facilitate conversion to VCS, primary care patients seeking stress, anxiety, and depression interventions found VCS acceptable during COVID-19. Future iterations of this program are proposed which incorporate procedural changes and facilitate relationship building between patients in VCS.

    View details for DOI 10.1177/2040622321990269

    View details for PubMedID 33633823

  • Completion Rate and Side-Effect Profile of Three-Month Isoniazid and Rifapentine Treatment for Latent Tuberculosis Infection in an Urban County Jail. Open forum infectious diseases Juarez-Reyes, M., Gallivan, M., Chyorny, A., O'Keeffe, L., Shah, N. S. 2016; 3 (1): ofv220-?

    Abstract

    In an urban jail population, 3 months of isoniazid and rifapentine (3HP) was associated with an 85% latent tuberculosis infection treatment completion rate compared with 18% in a standard 9-month isoniazid treatment group. Among the 91 patients who started 3HP therapy, there were 2 treatment discontinuations from adverse drug reactions.

    View details for DOI 10.1093/ofid/ofv220

    View details for PubMedID 26885547

    View details for PubMedCentralID PMC4753347